Google
Apple
English (USA)
English (UK)
English (India)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
BIOGEN INC. Toevoegen aan een lijst
PDF-rapport : Biogen Inc.
|
Geschatte realtime
Andere beurzen
|
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | |
| 246,48 USD | +3,01% | +5,78% | -11,05% | |
| 07/12 | BIOGEN INC. : Raymond James verhoogt advies naar kopen | ZM |
| 28/11 | Transcript : Biogen Inc. Presents at The 6th Annual Evercore ISI HealthCONx Conference, Nov-28-2023 09:10 AM | CI |
Totale waarde
| Start boekjaar : december | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Marktkapitalisatie 1 | 60 630 | 53 543 | 37 679 | 35 242 | 39 877 | 34 673 | - | - |
| Bedrijfswaarde 1 | 61 653 | 51 733 | 41 723 | 37 820 | 40 560 | 39 462 | 37 284 | 33 296 |
| K/w-verhouding | 13,9x | 9,44x | 9,87x | 23,1x | 13,3x | 25,1x | 16,1x | 14,6x |
| Dividendrendement | - | - | - | - | - | - | - | - |
| Marktkapitalisatie/omzet | 4,51x | 3,72x | 2,80x | 3,21x | 3,92x | 3,49x | 3,59x | 3,51x |
| Bedrijfswaarde/omzet | 4,58x | 3,60x | 3,10x | 3,44x | 3,99x | 3,98x | 3,87x | 3,37x |
| Bedrijfswaarde/EBITDA | 8,76x | 6,41x | 5,56x | 9,13x | 11,2x | 12,8x | 10,6x | 8,52x |
| Bedrijfswaarde/FCF | 11,4x | 7,88x | 11,0x | 11,2x | 35,5x | 19,3x | 16,4x | 13,2x |
| FCF Yield | 8,79% | 12,7% | 9,12% | 8,94% | 2,82% | 5,19% | 6,08% | 7,55% |
| Price to Book | 4,73x | 3,87x | 3,70x | 3,26x | 3,02x | 2,35x | 2,01x | 1,72x |
| Aantal aandelen (in duizenden) | 201 483 | 180 442 | 153 882 | 146 893 | 144 001 | 144 898 | - | - |
| Referentieprijs 2 | 301 | 297 | 245 | 240 | 277 | 239 | 239 | 239 |
| Datum van publicatie | 29/01/19 | 30/01/20 | 3/02/21 | 3/02/22 | 15/02/23 | - | - | - |
1USD in miljoenen2USD
Geschatte gegevens
Evolutie van de resultatenrekening (Jaargegevens)
| Start boekjaar : december | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Omzet 1 | 13 453 | 14 378 | 13 445 | 10 982 | 10 173 | 9 926 | 9 646 | 9 866 |
| EBITDA 1 | 7 038 | 8 070 | 7 504 | 4 144 | 3 618 | 3 073 | 3 525 | 3 908 |
| Bedrijfsresultaat (EBIT) 1 | 6 769 | 7 390 | 6 837 | 3 656 | 3 099 | 2 599 | 2 877 | 3 274 |
| Operationele Marge | 50,3% | 51,4% | 50,9% | 33,3% | 30,5% | 26,2% | 29,8% | 33,2% |
| Resultaat voor belastingen (EBT) 1 | 5 900 | 7 126 | 5 048 | 1 745 | 3 592 | 1 519 | 2 509 | 2 631 |
| Nettowinst (verlies) 1 | 4 431 | 5 889 | 4 001 | 1 556 | 3 047 | 1 339 | 2 056 | 2 257 |
| Nettomarge | 32,9% | 41,0% | 29,8% | 14,2% | 29,9% | 13,5% | 21,3% | 22,9% |
| WPA 2 | 21,6 | 31,4 | 24,8 | 10,4 | 20,9 | 9,52 | 14,8 | 16,4 |
| Free Cash Flow 1 | 5 417 | 6 564 | 3 805 | 3 382 | 1 144 | 2 048 | 2 267 | 2 514 |
| FCF-marge | 40,3% | 45,7% | 28,3% | 30,8% | 11,2% | 20,6% | 23,5% | 25,5% |
| Kasstroomconversie (ebitda) | 77,0% | 81,3% | 50,7% | 81,6% | 31,6% | 66,6% | 64,3% | 64,3% |
| Kasstroomconversie (nettowinst) | 122% | 111% | 95,1% | 217% | 37,5% | 153% | 110% | 111% |
| Dividend per aandeel 2 | - | - | - | - | - | - | - | - |
| Datum van publicatie | 29/01/19 | 30/01/20 | 3/02/21 | 3/02/22 | 15/02/23 | - | - | - |
1USD in miljoenen2USD
Geschatte gegevens
Evolutie van de resultatenrekening (Kwartaalgegevens)
| Start boekjaar : december | 2021 Q2 | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Omzet 1 | 2 775 | 2 779 | 2 734 | 2 532 | 2 589 | 2 509 | 2 544 | 2 463 | 2 456 | 2 530 | 2 460 | 2 375 | 2 433 | 2 456 | 2 484 |
| EBITDA 1 | 1 181 | 1 018 | 781 | 844 | 1 112 | 991 | 793 | 675 | 798 | 853 | 911 | 829 | 874 | 918 | 950 |
| Bedrijfsresultaat (EBIT) 1 | 1 108 | 885 | 646 | 709 | 977 | 870 | 673 | 468 | 674 | 728 | 620 | 656 | 719 | 759 | 780 |
| Operationele Marge | 39,9% | 31,9% | 23,6% | 28,0% | 37,7% | 34,7% | 26,5% | 19,0% | 27,5% | 28,8% | 25,2% | 27,6% | 29,5% | 30,9% | 31,4% |
| Resultaat voor belastingen (EBT) 1 | 582 | 291 | 405 | 347 | 1 270 | 1 371 | 604 | 438 | 708 | -141 | 472 | 678 | 698 | 706 | 727 |
| Nettowinst (verlies) 1 | 449 | 329 | 368 | 304 | 1 058 | 1 135 | 550 | 388 | 592 | -68,1 | 378 | 403 | 477 | 517 | 529 |
| Nettomarge | 16,2% | 11,8% | 13,5% | 12,0% | 40,9% | 45,2% | 21,6% | 15,7% | 24,1% | -2,69% | 15,4% | 17,0% | 19,6% | 21,0% | 21,3% |
| WPA 2 | 2,99 | 2,22 | 2,50 | 2,06 | 7,24 | 7,84 | 3,79 | 2,67 | 4,07 | -0,47 | 2,65 | 3,12 | 4,76 | 3,83 | 3,95 |
| Dividend per aandeel 2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Datum van publicatie | 22/07/21 | 20/10/21 | 3/02/22 | 3/05/22 | 20/07/22 | 25/10/22 | 15/02/23 | 25/04/23 | 25/07/23 | 8/11/23 | - | - | - | - | - |
1USD in miljoenen2USD
Geschatte gegevens
Balans
| Start boekjaar : december | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Nettoschuldpositie 1 | 1 023 | - | 4 044 | 2 578 | 683 | 4 789 | 2 612 | - |
| Nettokaspositie 1 | - | 1 810 | - | - | - | - | - | 1 376 |
| Hefboom (schuld/ebitda) | 0,15x | - | 0,54x | 0,62x | 0,19x | 1,56x | 0,74x | - |
| Free Cash Flow 1 | 5 417 | 6 564 | 3 805 | 3 382 | 1 144 | 2 048 | 2 267 | 2 514 |
| ROE (netto-inkomsten/eigen vermogen) | 42,0% | 47,7% | 45,2% | 26,6% | 21,2% | 15,5% | 16,1% | 16,2% |
| Eigen vermogen 1 | 10 558 | 12 342 | 8 841 | 5 858 | 14 345 | 8 637 | 12 762 | 13 887 |
| ROA (netto-inkomsten/totale activa) | 22,0% | 24,0% | 15,4% | 11,9% | 12,6% | 6,93% | 6,62% | 7,15% |
| Totale activa 1 | 20 161 | 24 583 | 25 927 | 13 124 | 24 216 | 19 336 | 31 067 | 31 543 |
| Nettoactief per aandeel 2 | 63,6 | 76,6 | 66,2 | 73,5 | 91,7 | 102 | 119 | 139 |
| Cashflow per aandeel 2 | 30,2 | 38,0 | 26,2 | 24,3 | 9,48 | 20,8 | 21,3 | 19,9 |
| Capex 1 | 771 | 515 | 425 | 258 | 240 | 292 | 283 | 274 |
| Capex/omzet | 5,73% | 3,58% | 3,16% | 2,35% | 2,36% | 2,94% | 2,93% | 2,77% |
| Datum van publicatie | 29/01/19 | 30/01/20 | 3/02/21 | 3/02/22 | 15/02/23 | - | - | - |
1USD in miljoenen2USD
Geschatte gegevens
WPA & Dividend
Historische koers/winstverhouding
Evolutie van de historische prestaties
Historische marktkapitalisatie/EBITDA
Trading rating :
Beleggingsrating :
ESG Refinitiv :
B-
Verkoop
Koop
Gemiddeld advies
Kopen
Aantal analisten
35
Laatste slotkoers
239,29USD
Gemiddelde koersdoel
315,5USD
Spread / Gemiddelde doel
+31,85%
Herzieningen van WPA
| Vaira. 1 jan. | Kapi. | |
|---|---|---|
| -11,05% | 34 673 M $ | |
| -6,95% | 84 806 M $ | |
| -14,37% | 38 355 M $ | |
| +9,66% | 20 852 M $ | |
| -9,82% | 17 507 M $ | |
| -52,21% | 15 921 M $ | |
| +4,54% | 15 625 M $ | |
| -31,26% | 12 259 M $ | |
| +35,86% | 8 812 M $ | |
| -46,63% | 8 524 M $ |
- Beurs
- Aandelen
- Aandeel Biogen Inc. - Nasdaq
- Financiën Biogen Inc.
